BIOC(Delisted)
Biocept·NASDAQ
--
--(--)
BIOC fundamentals
Biocept (BIOC) released its earnings on Aug 10, 2017: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Aug 10, 2017
EPS
Revenue
Revenue & Expenses
BIOC has released its 2023 Q2 earnings report, with revenue of 589.00K, reflecting a YoY change of -89.88%, and net profit of -3.63M, showing a YoY change of 63.85%. The Sankey diagram below clearly presents BIOC's revenue sources and cost distribution.
Key Indicators
Biocept (BIOC) key financial stats and ratios, covering profitability, financial health, and leverage.
Biocept (BIOC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Biocept (BIOC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Biocept (BIOC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Biocept (BIOC) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Biocept (BIOC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
